Lv11
40 积分 2022-07-15 加入
Concurrent Chemoradiation ± Atezolizumab (atezo) in Limited-Stage Small Cell Lung Cancer (LS-SCLC): Results of NRG Oncology/Alliance LU005
3小时前
已完结
Creating and Implementing a Principal Investigator Tool Kit for Enhancing Accrual to Late Phase Clinical Trials: Development and Usability Study
3小时前
求助中
Design and Rationale for a Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Sugemalimab as Consolidation Therapy in Patients With Limited-Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent or Sequential Chemoradiotherapy: The SURPASS Study
4小时前
已完结
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
9天前
已完结
Effectiveness of narrowband ultraviolet B monotherapy versus combination therapy with systemic agents in patients with early‐stage mycosis fungoides and the association with plaque lesions
9天前
已完结
Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China
11天前
已完结
Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies
26天前
已完结
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
1个月前
已关闭
Time to lymphoma treatment within 24 months in ‘watch and wait’ follicular lymphoma is associated with inferior outcomes: A multicentre analysis
1个月前
已完结
Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies
1个月前
已完结
皖公网安备34019202002308
